PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-05-22 (2)

Date Title Company
22-May-2026 858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting Businesswire